Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

47.4K
Overview
47.4K
Cross-reactivity00:42

Cross-reactivity

31.8K
Overview
31.8K
Humoral Immune Responses01:36

Humoral Immune Responses

78.9K
Overview
78.9K
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

1.1K
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
1.1K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

12.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
12.8K
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

833
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
833

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Inflammatory immune modulators of AML lung infiltration and respiratory failure.

Nature immunology·2026
Same author

Inhibiting glycan degradation prevents HIV-induced inflammaging and cognitive impairment.

Med (New York, N.Y.)·2026
Same author

LIF-Induced Tumor Plasticity Establishes an Immunosuppressive Myeloid Niche in LKB1-Mutant Lung Cancer.

Cancer discovery·2026
Same author

Peripheral immune-inducer dendritic cells drive early-life allergic inflammation.

Nature·2026
Same author

Type 2 immune history imprints local training in nerve and airway associated interstitial macrophages (NAMs) for disease tolerance during lethal respiratory viral infection.

Research square·2026
Same author

Chromatin-mediated anticipatory control of type I interferon production in plasmacytoid dendritic cells.

Immunity·2026

Related Experiment Video

Updated: Oct 28, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.5K

Beyond neutralization for BNT162b2 mRNA vaccination.

Payal Damani-Yokota1, Stephen T Yeung2, Kamal M Khanna3

  • 1Department of Microbiology, New York University Langone Health, New York, NY, USA.

Cell Host & Microbe
|July 15, 2021
PubMed
Summary

A single BNT162b2 mRNA vaccine dose elicits robust humoral and T cell immunity against SARS-CoV-2. Previous infection enhances vaccine-induced immune responses, offering broader protection against the virus.

More Related Videos

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

11.9K
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

9.7K

Related Experiment Videos

Last Updated: Oct 28, 2025

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays
06:03

Author Spotlight: Advancing Immune Monitoring in Critical Care Patients Using Whole Blood Assays

Published on: September 20, 2024

1.5K
Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies
07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

11.9K
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
08:09

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope

Published on: March 24, 2017

9.7K

Area of Science:

  • Immunology
  • Virology
  • Vaccinology

Background:

  • Effective SARS-CoV-2 immunity requires both antibody neutralization and T cell effector functions.
  • Understanding vaccine-induced immune responses is crucial for controlling the pandemic.

Purpose of the Study:

  • To characterize the humoral and T cell responses following a single dose of the BNT162b2 mRNA vaccine.
  • To compare these responses in individuals with and without prior SARS-CoV-2 exposure.

Main Methods:

  • Analysis of antibody levels and neutralization capacity.
  • Assessment of T cell responses, including cytokine production and proliferation.
  • Comparison between previously infected and naive individuals.

Main Results:

  • A single BNT162b2 mRNA vaccine dose induced significant antibody and T cell responses.
  • Individuals with prior SARS-CoV-2 exposure exhibited augmented humoral and T cell immunity after vaccination.
  • Vaccination boosted pre-existing immunity in previously infected individuals.

Conclusions:

  • A single dose of BNT162b2 mRNA vaccine is effective in generating a comprehensive immune response.
  • Prior SARS-CoV-2 infection synergizes with vaccination to enhance protective immunity.
  • These findings have implications for vaccination strategies and understanding immune memory.